Manlio Mencoboni

Outcome of EGFR inhibitors treatment in advanced NSCLC patients, not enrolled in clinical trials.

M. Mencoboni, A. Garuti, R. Filiberti, 2016, Neoplasma.

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time

G. Ceresoli, M. Mencoboni, F. Grosso, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

C. Gridelli, G. Ceresoli, M. Piccirillo, 2023, The Lancet.

Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis

M. Mencoboni, A. Addeo, G. Banna, 2018, Clinical and Translational Oncology.